Literature DB >> 24371299

Arrestin(g) podocyte injury with endothelin antagonism.

Roderick J Tan1, Youhua Liu.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 24371299      PMCID: PMC3935599          DOI: 10.1681/ASN.2013111230

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  15 in total

Review 1.  Beta-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold?

Authors:  Kathryn A DeFea
Journal:  Cell Signal       Date:  2010-10-12       Impact factor: 4.315

2.  Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.

Authors:  Weichun He; Young Sun Kang; Chunsun Dai; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 10.121

Review 3.  Adriamycin nephropathy: a model of focal segmental glomerulosclerosis.

Authors:  Vincent W S Lee; David C H Harris
Journal:  Nephrology (Carlton)       Date:  2011-01       Impact factor: 2.506

Review 4.  Conceptual model of CKD: applications and implications.

Authors:  Andrew S Levey; Lesley A Stevens; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2009-03       Impact factor: 8.860

5.  Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria.

Authors:  Yingjian Li; Young Sun Kang; Chunsun Dai; Lawrence P Kiss; Xiaoyan Wen; Youhua Liu
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

6.  Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.

Authors:  Chunsun Dai; Donna B Stolz; Lawrence P Kiss; Satdarshan P Monga; Lawrence B Holzman; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

Review 7.  The endothelin system and its antagonism in chronic kidney disease.

Authors:  Neeraj Dhaun; Jane Goddard; David J Webb
Journal:  J Am Soc Nephrol       Date:  2006-03-15       Impact factor: 10.121

8.  Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis.

Authors:  Laura Rosanò; Roberta Cianfrocca; Stefano Masi; Francesca Spinella; Valeriana Di Castro; Annamaria Biroccio; Erica Salvati; Maria Rita Nicotra; Pier Giorgio Natali; Anna Bagnato
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

9.  Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.

Authors:  Elena Gagliardini; Daniela Corna; Carla Zoja; Fabio Sangalli; Fabiola Carrara; Matteo Rossi; Sara Conti; Daniela Rottoli; Lorena Longaretti; Andrea Remuzzi; Giuseppe Remuzzi; Ariela Benigni
Journal:  Am J Physiol Renal Physiol       Date:  2009-08-12

10.  Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.

Authors:  A Fogo; Y Yoshida; A D Glick; T Homma; I Ichikawa
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

View more
  3 in total

Review 1.  Endothelin and the glomerulus in chronic kidney disease.

Authors:  Matthias Barton; Andrey Sorokin
Journal:  Semin Nephrol       Date:  2015-03       Impact factor: 5.299

Review 2.  Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.

Authors:  Lili Zhou; Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

3.  β-Arrestin 1/2 Aggravates Podocyte Apoptosis of Diabetic Nephropathy via Wnt/β-Catenin Pathway.

Authors:  Yao Wang; Han Li; Shu-Ping Song
Journal:  Med Sci Monit       Date:  2018-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.